Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of hydroxyurea in treating patients who
have recurrent and/or unresectable meningioma.